La cadena de opciones muestra datos clave de las opciones de acciones de Earth Life Sciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Earth Life Sciences..

Earth Life Sciences (OTC:CLTS) Bolsa, Cadena de Opciones

Earth Life Sciences Inc offers Artificial Intelligence (AI)-driven mileage-based loyalty system for public transportation. The Miltean's AI platform enables an increase of ridership, decongestion analysis, interruption of service compensation, congestion management, prediction and analysis of ridership usage patterns. The firm caters to public traffic management systems and team up relationships between private and public enterprise.

News

IPOs

MSGY

Masonglory Shares Halted On Circuit Breaker To The Downside, Stock Now Down -2.5%

Wolfe Research analyst George Notter initiates coverage on Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) with a Outperform rating.

Initiation

Analyst Ratings

COHR

Wolfe Research Initiates Coverage On Coherent with Outperform Rating

JP Morgan analyst Brian Ossenbeck maintains Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) with a Overweight and raises the price target from $272 to $282.

Price Target

JP Morgan Maintains Overweight on Norfolk Southern, Raises Price Target to $282

Trading Ideas

TLIH

Ten-League International Holdings Shares Open For Trade At $3.87/Share; IPO Priced At $4/Share On On 2.24M Shares

WIIM

BWXT

BWX Technologies shares are trading lower after Deutsche Bank downgraded the stock from Buy to Hold.

JP Morgan analyst Jimmy Bhullar maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and raises the price target from $86 to $95.

JP Morgan Maintains Overweight on MetLife, Raises Price Target to $95

Masonglory Shares Open For Trade At $4.28/Share; IPO Priced At $4/Share On 1.5M Shares

Wolfe Research analyst George Notter initiates coverage on Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Peer Perform rating.

CALX

Wolfe Research Initiates Coverage On Calix with Peer Perform Rating

PROK

ProKidney Corp. Shares Halted On Circuit Breaker To The Upside, Stock Now Up 290.8%

JP Morgan analyst Jimmy Bhullar maintains Lincoln National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>) with a Underweight and raises the price target from $38 to $41.

JP Morgan Maintains Underweight on Lincoln National, Raises Price Target to $41

As tariff fears ripple across markets with <a href="https://www.benzinga.com/topic/donald-trump">President Donald Trump</a> sending <a href="https://www.benzinga.com/news/politics/25/07/46263813/trump-to-send-take-it-or-leave-it-tariff-letters-to-12-countries-on-monday-report">tariff letters to 12 countries</a>, small-cap resilience is stealing the spotlight. The Russell 2000 index is soaring toward creating new all-time highs. The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), which tracks the Russell 2000 index, is up over 25% from April 8 lows.
The recovery is powered in part by a few unlikely stars &#8211; Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), NuScale Power Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) and Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) &#8211; each bucking macro gloom with year-to-date gains of 159%, 107%, and 95% respectively.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46248969/nuscales-200-surge-altman-oklo-not-sitting-out">NuScale&#8217;s 200% Surge Supercharged By NRC, Oklo&#8217;s Not Sitting Out</a>
Trump's trade rhetoric, including a potential 10% blanket tariff on imports, has fueled concerns about volatility for multinationals and global supply chains. But these three Russell 2000 names have sidestepped the turmoil, each riding powerful secular trends that appear tariff-resistant, for now.
<h2 class="wp-block-heading">Oklo's Nuclear Momentum</h2>
The newly listed nuclear microreactor company has surged over 159% YTD as investors pile into next-gen clean energy plays. 
Despite a recent pullback, Oklo's buzz around small modular reactor tech and federal tailwinds has turned it into a speculative darling.
<h2 class="wp-block-heading">NuScale's Over 100% Rebound</h2>
NuScale Power is riding a similar wave. After spending much of 2023 in the red, recovering in 2024, shares have doubled in 2025 on a YTD basis on renewed investor interest in SMRs and a post-NRC approval boost.
Tariffs may impact construction costs, but the momentum for clean energy remains the bigger story.
<h2 class="wp-block-heading">Hims: Hair, Health And Heft</h2>
In the consumer space, Hims is on a tear. With 95% YTD gains, the digital health company is turning recession fears into growth tailwinds. Its lean, asset-light model and sticky customer base have insulated it from macroeconomic shocks and tariffs.
In a market where mega-caps wobble on every macro headline, these small caps are making a big noise. Their individual fundamentals, combined with the Russell 2000's stealth climb, suggest that some pockets of the market are quietly thriving &#8211; even with tariff clouds gathering on the horizon.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/07/46294263/another-july-another-sp-500-rally-but-somethings-seriously-off-this-time">Another July, Another S&amp;P 500 Rally &#8211; But Something&#8217;s Seriously Off This Time</a></li>
</ul>
Photo: Shutterstock

Government

Regulations

Small Cap Analysis

Small Cap

Movers

Hims & Hers Health, Inc. Class A Common Stock

HIMS

OKLO

Oklo, NuScale, Hims Defy Trump Tariffs - And Power The Russell 2000 Toward New Highs

Wolfe Research analyst George Notter initiates coverage on Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Outperform rating.

CIEN

Wolfe Research Initiates Coverage On Ciena with Outperform Rating

Macro Economic Events

Econ #s

Economics

NY Fed 1-Year Consumer Inflation Expectations For June 3.0% Vs 3.2% Prior

Wolfe Research analyst George Notter initiates coverage on Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) with a Outperform rating.

AXON

Wolfe Research Initiates Coverage On Axon Enterprise with Outperform Rating

Sharplink Gaming Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares are trading higher Tuesday morning following the announcement of another significant Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) purchase. The company, which has pivoted to an ETH-centric treasury strategy, <a href="https://www.benzinga.com/pressreleases/25/07/g46292899/sharplink-grows-eth-holdings-to-205-634-earns-322-eth-in-staking-rewards-since-launch-of-treasury-">acquired</a> an additional 7,689 ETH last week at an average price of $2,501 per coin.
What To Know: This latest acquisition brings SharpLink&#8217;s total holdings to 205,634 ETH. The purchases were funded by the company&#8217;s At-The-Market facility, which raised approximately $64.0 million in net proceeds between June 28 and July 4. A substantial portion of this capital, about $37.2 million, is still slated for ETH purchases in the current week.
The news comes after a <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46284263/whats-going-on-with-sharplink-gaming-sbet-stock">volatile Monday</a> where the stock surged as the company prepared to ring the Nasdaq closing bell, celebrating its new strategy. Since adopting Ethereum as its primary treasury reserve asset in May, SharpLink&#8217;s stock has soared over 300%.
The company also reported earning approximately 100 ETH in staking rewards last week, having committed 100% of its holdings to yield-generating protocols. To increase transparency, SharpLink has also introduced a new metric, &#8220;ETH Concentration,&#8221; which the <a href="https://www.benzinga.com/pressreleases/25/07/g46292899/sharplink-grows-eth-holdings-to-205-634-earns-322-eth-in-staking-rewards-since-launch-of-treasury-">company says</a> has risen 19% in the last three weeks, reflecting its growing exposure relative to its equity structure.
Benzinga Edge Rankings: Based on <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> data, SBET demonstrates exceptionally strong momentum, registering a high score of 95.21. This indicates a powerful recent trend in the stock&#8217;s price performance. 
In contrast, the stock receives a very low value score of 2.10, suggesting that according to Benzinga&#8217;s metrics, it may be significantly overvalued.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SBET shares are trading higher by 16.8% to $14.80 Tuesday morning. The stock has a 52-week high of $124.12 and a 52-week low of $2.26.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46284263/whats-going-on-with-sharplink-gaming-sbet-stock">What&#8217;s Going On With SharpLink Gaming Stock?</a>
<h2 class="wp-block-heading">How To Buy SBET Stock</h2>
By now you're likely curious about how to participate in the market for SharpLink Gaming &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of SharpLink Gaming, which is trading at $14.80 as of publishing time, $100 would buy you 6.76 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

$ETH

SBET

SharpLink Continues Ethereum Buying Spree, Stock Surges

JP Morgan analyst Brian Ossenbeck maintains JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) with a Overweight and raises the price target from $150 to $159.

JBHT

JP Morgan Maintains Overweight on JB Hunt Transport Servs, Raises Price Target to $159

Wolfe Research analyst George Notter initiates coverage on Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Outperform rating.

ANET

Wolfe Research Initiates Coverage On Arista Networks with Outperform Rating

JP Morgan analyst Jessica Fye maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Overweight and raises the price target from $90 to $111.

INSM

JP Morgan Maintains Overweight on Insmed, Raises Price Target to $111

Wolfe Research analyst George Notter initiates coverage on Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) with a Peer Perform rating.

AAOI

Wolfe Research Initiates Coverage On Applied Optoelectronics with Peer Perform Rating

Park Ha Biological Technology Co. Shares Halted On Circuit Breaker To The Downside, Stock Now Down -6.12%

EARTH LIFE SCIENCES by Earth Life Sciences Inc.

Comments

Earth Life Sciences

Earth Life Sciences (CLTS) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL